AU5398494A - Five-membered heterocycles - Google Patents
Five-membered heterocyclesInfo
- Publication number
- AU5398494A AU5398494A AU53984/94A AU5398494A AU5398494A AU 5398494 A AU5398494 A AU 5398494A AU 53984/94 A AU53984/94 A AU 53984/94A AU 5398494 A AU5398494 A AU 5398494A AU 5398494 A AU5398494 A AU 5398494A
- Authority
- AU
- Australia
- Prior art keywords
- membered heterocycles
- heterocycles
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4302051A DE4302051A1 (en) | 1993-01-26 | 1993-01-26 | 5-membered heterocycles, process for their preparation and medicaments containing these compounds |
| DE4302051 | 1993-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5398494A true AU5398494A (en) | 1994-08-04 |
Family
ID=6478937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU53984/94A Abandoned AU5398494A (en) | 1993-01-26 | 1994-01-27 | Five-membered heterocycles |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0608858A1 (en) |
| JP (1) | JPH072851A (en) |
| KR (1) | KR940018382A (en) |
| CN (1) | CN1097753A (en) |
| AU (1) | AU5398494A (en) |
| BG (1) | BG98409A (en) |
| CA (1) | CA2114178A1 (en) |
| CZ (1) | CZ18194A3 (en) |
| DE (1) | DE4302051A1 (en) |
| FI (1) | FI940378A (en) |
| HU (1) | HU9400217D0 (en) |
| IL (1) | IL108436A0 (en) |
| NO (1) | NO940261L (en) |
| NZ (1) | NZ250762A (en) |
| PL (1) | PL302018A1 (en) |
| RU (1) | RU94002482A (en) |
| SK (1) | SK8394A3 (en) |
| ZA (1) | ZA94495B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7557131B2 (en) | 2005-01-20 | 2009-07-07 | Pfizer Inc | Substituted triazole derivatives as oxytocin antagonists |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
| ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
| EP0858457A1 (en) * | 1995-10-20 | 1998-08-19 | Dr. Karl Thomae GmbH | 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them |
| US6083986A (en) * | 1996-07-26 | 2000-07-04 | Icagen, Inc. | Potassium channel inhibitors |
| US6333337B1 (en) | 1998-01-27 | 2001-12-25 | Icagen, Inc. | Potassium channel inhibitors |
| CN1314899A (en) * | 1998-07-01 | 2001-09-26 | 武田药品工业株式会社 | Retinoid-associated receptor regulators |
| US7084279B1 (en) | 1999-02-11 | 2006-08-01 | Emisphere Technologies Inc. | Oxadiazole compounds and compositions for delivering active agents |
| ES2251976T3 (en) * | 1999-02-11 | 2006-05-16 | Emisphere Technologies, Inc. | COMPOUNDS AND COMPOSITIONS OF OXADIAZOL TO PROVIDE ACTIVE AGENTS. |
| US6458794B2 (en) | 1999-12-21 | 2002-10-01 | Icagen, Inc. | Potassium channel inhibitors |
| AU2000223275A1 (en) * | 2000-02-08 | 2001-08-20 | Yamanouchi Pharmaceutical Co..Ltd. | Novel triazole derivatives |
| RU2002133666A (en) * | 2000-05-19 | 2007-05-10 | Мерк Патент ГмбХ (DE) | TRIAZOLE DERIVATIVES |
| US6566380B2 (en) | 2000-07-25 | 2003-05-20 | Icagen, Inc. | Potassium channel inhibitors |
| US6620849B2 (en) | 2000-07-26 | 2003-09-16 | Icafen, Inc. | Potassium channel inhibitors |
| US6849634B2 (en) | 2000-12-21 | 2005-02-01 | Icagen | Potassium channel inhibitors |
| EP1405636A4 (en) * | 2001-06-26 | 2009-04-15 | Takeda Pharmaceutical | Function regulator for retinoid relative receptor |
| US7390813B1 (en) | 2001-12-21 | 2008-06-24 | Xenon Pharmaceuticals Inc. | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents |
| US7087604B2 (en) | 2002-03-08 | 2006-08-08 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| WO2004050642A1 (en) | 2002-11-27 | 2004-06-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1, 2, 3- triazole amide derivatives as cytokine inhibitors |
| US7078419B2 (en) | 2003-03-10 | 2006-07-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Cytokine inhibitors |
| EP1622569B1 (en) | 2003-04-24 | 2015-12-02 | Incyte Corporation | Aza spiro alkane derivatives as inhibitors of metallproteases |
| EP1648874B1 (en) | 2003-07-30 | 2011-10-05 | Xenon Pharmaceuticals Inc. | Piperazine derivatives and their use as therapeutic agents |
| EP1692116B1 (en) | 2003-12-03 | 2011-03-09 | Boehringer Ingelheim Pharmaceuticals Inc. | 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| WO2005090333A1 (en) | 2004-03-09 | 2005-09-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| JP4865702B2 (en) | 2004-05-03 | 2012-02-01 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | Cytokine inhibitor |
| US7485657B2 (en) | 2004-05-12 | 2009-02-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
| TW200626139A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| MX2007003332A (en) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors. |
| WO2006034440A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| TW200626572A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| EP1814551A2 (en) | 2004-09-20 | 2007-08-08 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| BRPI0515483A (en) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | heterocyclic derivatives for the treatment of stearoyl coa desaturase mediated diseases |
| BRPI0515488A (en) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | heterocyclic derivatives and their use as therapeutic agents |
| US7531560B2 (en) | 2004-11-10 | 2009-05-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
| EP2540296A1 (en) | 2005-06-03 | 2013-01-02 | Xenon Pharmaceuticals Inc. | Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| TW200811164A (en) * | 2006-05-12 | 2008-03-01 | Jerini Ag | New heterocyclic compounds for the inhibition of integrins and use thereof |
| WO2007143600A2 (en) | 2006-06-05 | 2007-12-13 | Incyte Corporation | Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases |
| TW200813018A (en) | 2006-06-09 | 2008-03-16 | Astrazeneca Ab | Novel compounds |
| JP2010501567A (en) | 2006-08-24 | 2010-01-21 | ノバルティス アクチエンゲゼルシャフト | 2- (pyrazin-2-yl) -thiazole and 2- (1H-pyrazole-3-) as stearoyl-CoA desaturase (SCD) inhibitors for the treatment of metabolic, cardiovascular and other disorders Yl) thiazole derivatives and related compounds |
| ATE532770T1 (en) | 2006-09-05 | 2011-11-15 | Kyowa Hakko Kirin Co Ltd | IMIDAZOLE DERIVATIVE |
| MY148657A (en) | 2007-04-27 | 2013-05-15 | Purdue Pharma Lp | Trpv1 antagonists and uses thereof |
| US8119661B2 (en) | 2007-09-11 | 2012-02-21 | Astrazeneca Ab | Piperidine derivatives and their use as muscarinic receptor modulators |
| SG186885A1 (en) | 2010-06-04 | 2013-02-28 | Albany Molecular Res Inc | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
| ME02609B (en) | 2011-06-22 | 2017-06-20 | Purdue Pharma Lp | Trpv1 antagonists including dihydroxy substituent and uses thereof |
| WO2014122474A1 (en) | 2013-02-07 | 2014-08-14 | Takeda Pharmaceutical Company Limited | Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists |
| GB201810071D0 (en) * | 2018-06-19 | 2018-08-08 | Univ Oslo Hf | Compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL98757A (en) * | 1990-07-18 | 1997-01-10 | Novo Nordisk As | Piperidine derivatives their preparation and pharmaceutical compositions containing them |
| DE4124942A1 (en) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS |
-
1993
- 1993-01-26 DE DE4302051A patent/DE4302051A1/en not_active Withdrawn
-
1994
- 1994-01-24 SK SK83-94A patent/SK8394A3/en unknown
- 1994-01-24 BG BG98409A patent/BG98409A/en unknown
- 1994-01-25 HU HU9400217A patent/HU9400217D0/en unknown
- 1994-01-25 CA CA002114178A patent/CA2114178A1/en not_active Abandoned
- 1994-01-25 KR KR1019940001441A patent/KR940018382A/en not_active Application Discontinuation
- 1994-01-25 CN CN94100575A patent/CN1097753A/en active Pending
- 1994-01-25 NO NO940261A patent/NO940261L/en unknown
- 1994-01-25 ZA ZA94495A patent/ZA94495B/en unknown
- 1994-01-25 JP JP6006295A patent/JPH072851A/en active Pending
- 1994-01-25 RU RU94002482/04A patent/RU94002482A/en unknown
- 1994-01-25 PL PL94302018A patent/PL302018A1/en unknown
- 1994-01-26 CZ CZ94181A patent/CZ18194A3/en unknown
- 1994-01-26 FI FI940378A patent/FI940378A/en not_active Application Discontinuation
- 1994-01-26 EP EP94101125A patent/EP0608858A1/en not_active Withdrawn
- 1994-01-26 NZ NZ250762A patent/NZ250762A/en unknown
- 1994-01-26 IL IL10843694A patent/IL108436A0/en unknown
- 1994-01-27 AU AU53984/94A patent/AU5398494A/en not_active Abandoned
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7557131B2 (en) | 2005-01-20 | 2009-07-07 | Pfizer Inc | Substituted triazole derivatives as oxytocin antagonists |
| US8207198B2 (en) | 2005-01-20 | 2012-06-26 | Pfizer Inc. | Substituted triazole derivatives as oxytocin antagonists |
| US9023872B2 (en) | 2005-01-20 | 2015-05-05 | Ixchelsis Limited | Substituted triazole derivatives as oxytocin antagonists |
| US10150752B2 (en) | 2005-01-20 | 2018-12-11 | Ixchelsis Limited | Substituted triazole derivatives as oxytocin antagonists |
Also Published As
| Publication number | Publication date |
|---|---|
| RU94002482A (en) | 1996-08-27 |
| SK8394A3 (en) | 1995-02-08 |
| FI940378A0 (en) | 1994-01-26 |
| EP0608858A1 (en) | 1994-08-03 |
| FI940378A (en) | 1994-07-27 |
| IL108436A0 (en) | 1994-04-12 |
| NZ250762A (en) | 1995-08-28 |
| DE4302051A1 (en) | 1994-07-28 |
| PL302018A1 (en) | 1994-08-08 |
| NO940261D0 (en) | 1994-01-25 |
| CZ18194A3 (en) | 1994-11-16 |
| ZA94495B (en) | 1995-07-25 |
| JPH072851A (en) | 1995-01-06 |
| BG98409A (en) | 1994-09-30 |
| HU9400217D0 (en) | 1994-05-30 |
| NO940261L (en) | 1994-07-27 |
| KR940018382A (en) | 1994-08-16 |
| CN1097753A (en) | 1995-01-25 |
| CA2114178A1 (en) | 1994-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5398494A (en) | Five-membered heterocycles | |
| AU695661B2 (en) | 5-membered heteroaryl-oxazolidinones | |
| AU5891494A (en) | Heterocyclic derivative | |
| AU657350B2 (en) | Heterocyclic compounds | |
| AU7159994A (en) | 3-aryl-4-hydroxy-delta3-dihydrofuranone derivatives | |
| AU6231894A (en) | Waterproof oversock | |
| AU2056992A (en) | Heterocyclic compounds | |
| AU6001594A (en) | Imidazoazines | |
| AU4156293A (en) | Thiazolylvinylphenyl derivatives | |
| AU7919094A (en) | Imidazopyridine | |
| AU1272597A (en) | Tricyclic herbicidal heterocycles | |
| AU1040992A (en) | Nitrogen heterocycles | |
| AU6433294A (en) | Sensor | |
| AU2216495A (en) | N-cyanoaryl nitrogen heterocycles | |
| AU5513094A (en) | Condensed five-membered heterocyclic compounds | |
| AU5161593A (en) | Heterocyclic compound | |
| AU6348794A (en) | Imidazopyridine | |
| AU4982293A (en) | Novel heterocyclic compound | |
| AU3384593A (en) | N-aryl-nitrogen heterocycles | |
| AU6593296A (en) | Herbicidal phenylmethoxyphenyl heterocycles | |
| AU3406793A (en) | 2-oxoquinoline derivatives | |
| AU3195993A (en) | Heterocyclic derivatives | |
| AU5798394A (en) | Thiadiazinones | |
| AU6259294A (en) | Life-savingfloat | |
| AU3697893A (en) | Propenoyl-imidazole derivatives |